KAHRAMAN, D. C. And ATALAY, R. 2016. Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment. 24th Biennial Congress of the European Association for Cancer Research , (Manchester, England).

KAHRAMAN, D. C., & ATALAY, R., (2016). Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment . 24th Biennial Congress of the European Association for Cancer Research, Manchester, England

KAHRAMAN, DENİZ, And RENGÜL ATALAY. "Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment," 24th Biennial Congress of the European Association for Cancer Research, Manchester, England, 2016

KAHRAMAN, DENİZ C. And ATALAY, RENGÜL. "Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment." 24th Biennial Congress of the European Association for Cancer Research , Manchester, England, 2016

KAHRAMAN, D. C. And ATALAY, R. (2016) . "Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment." 24th Biennial Congress of the European Association for Cancer Research , Manchester, England.

@conferencepaper{conferencepaper, author={DENİZ CANSEN KAHRAMAN And author={RENGÜL ATALAY}, title={Sequential treatment of HCC cells with mTOR pathway inhibitors prior to Sorafenib attenuates cancer stem cell enrichment}, congress name={24th Biennial Congress of the European Association for Cancer Research}, city={Manchester}, country={England}, year={2016}}